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Original Article
CEDNIK: Phenotypic and Molecular
Characterization of an Additional Patient
and Review of the Literature
Tina Hsu, BA1, Carrie C. Coughlin, MD2,3,
Kristin G. Monaghan, PhD, FACMG4, Elise Fiala, MS5,
Robert C. McKinstry, MD, PhD3,6, Alex R. Paciorkowski, MD7,
and Marwan Shinawi, MD, FACMG5
Abstract
Synaptosomal-associated protein 29 (SNAP29) is a t-SNARE protein that is implicated in intracellular vesicle fusion. Mutations in
the SNAP29 gene have been associated with cerebral dysgenesis, neuropathy, ichthyosis, and keratoderma syndrome (CEDNIK).
In patients with 22q11.2 deletion syndrome, mutations in SNAP29 on the nondeleted chromosome are linked to similar ichthyotic
and neurological phenotypes. Here, the authors report a patient with cerebral dysgenesis, neuropathy, ichthyosis, and
keratoderma syndrome who presented with global developmental delay, polymicrogyria, dysgenesis of the corpus callosum,
optic nerve dysplasia, gaze apraxia, and dysmorphic features. He has developed ichthyosis and palmoplantar keratoderma as he
has grown. Exome sequencing identified a homozygous nonsense mutation in SNAP29 gene designated as c.85C>T (p.Arg29X).
The authors compare the findings in the proband with previously reported cases. The previously unreported mutation in this
patient and his phenotype add to the characterization of cerebral dysgenesis, neuropathy, ichthyosis, and keratoderma syndrome
and the accumulating scientific evidence that implicates synaptic protein dysfunction in various neuroectodermal conditions.
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Synaptosomal-associated protein 29 (SNAP29) is a 258-amino
acid protein encoded by a 5-exon gene located on 22q11.21,
primarily localized to intracellular membrane structures and
involved in multiple membrane trafficking processes.1
SNAP29 has 2 soluble N-ethylmaleimide-sensitive fusion
protein attachment protein receptor (SNARE) domains that
bind to multiple syntaxins and aid in vesicle fusion with
target membranes during the processes of endocytic recycling
and cell motility.2 SNAP29 is also involved in autophagy
through controlling autophagosome membrane fusion with
the lysosome membrane and plays a role in ciliogenesis by
regulating membrane fusions.3,4
Loss-of-function mutations in SNAP29 have been shown to
cause autosomal recessive cerebral dysgenesis, neuropathy,
ichthyosis, and keratoderma syndrome (CEDNIK).5-7
Moreover, patients with hemizygous deletions of 22q11.2
combined with mutations in the nondeleted SNAP29 display
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many of the features present in CEDNIK, confirming the loss-
of-function mechanism.8
Patients with CEDNIK typically present with ichthyosis
(dry, scaly skin), keratoderma (marked thickening of skin, typi-
cally of the palms and soles), intellectual disability, microce-
phaly, facial dysmorphism, hypoplastic optic discs,
sensorineural deafness, and cachexia, among other features.5,9
Brain magnetic resonance imaging (MRI) of patients with cer-
ebral dysgenesis, neuropathy, ichthyosis, and keratoderma
shows corpus callosum dysgenesis and cortical dysplasia with
pachygyria and polymicrogyria.5-8
In line with these observations, animal studies have shown
that both total SNAP29 knockout mice and keratinocyte-
specific knockout mice have neonatal lethality, acanthosis,
hyperkeratosis, abnormal keratinocyte differentiation, and
increased proliferation.2 Mutant mice have decreased
deposition of lamellar body contents into the epidermis, as
shown by their altered epidermal lipid distribution, as well as
malformed lamellar bodies and an impaired epidermal barrier.
They also have disturbed epidermal differentiation, as shown
by their thickened stratum corneum. Similarly,Drosophila flies
possessing a loss-of-function SNAP29 mutation have altered
autophagy and endoplastic reticulum function that lead to
impaired vesicle trafficking.10 These findings help to explain
the neurological and dermatological findings seen in cerebral
dysgenesis, neuropathy, ichthyosis, and keratoderma
syndrome.
Here, the authors report a patient with a novel homozy-
gous pathogenic variant designated as c.85C>T (p.Arg29X)
in SNAP29. The proband has a constellation of findings
consistent with cerebral dysgenesis, neuropathy, ichthyosis,
and keratoderma syndrome including neurological
impairment, brain malformation, global developmental
delay/intellectual disability, optic nerve dysplasia, facial
dysmorphism, palmoplantar keratoderma, and ichthyosis.
Clinical Report
The patient is a 10-year-old Jordanian American male born at
35 weeks’ gestation via induced vaginal delivery to a gravida 3
para 3 23-year-old mother and 27-year-old father. His parents
are first cousins and are both healthy. The patient has a 1-year-
old sister, 6-year-old brother, and a 12-year-old sister; all are
healthy with normal development. The patient has 2 paternal
cousins with reportedly similar clinical features (Figure 1A).
The authors have not examined these patients and their parents
declined to participate in this study. The proband’s birth weight
was 2.7 kg (75th percentile) and length was 50.8 cm (>97th
percentile). Pregnancy was uncomplicated, and prenatal ultra-
sounds were normal. Neonatal course was complicated by
breathing difficulties and sepsis, and the patient remained in
the neonatal intensive care unit for 40 days. Between the ages
of 3 months and 1 year, he was hospitalized 6 times for epi-
sodes of pneumonia.
Figure 1. Family tree and clinical features. A, Pedigree of the family. B, Frontal view of the proband. Note synophrys, hirsutism, low frontal
hairline, bushy eyebrows, large nose, and deep-set eyes. C, Left foot heel with xerosis and hyperkeratotic plaques. D, Right hand with a
hyperkeratotic plaque on hypothenar eminence. The findings in C and D are consistent with palmoplantar keratoderma.
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The patient exhibited developmental delays, including def-
icits in gross and fine motor skills as well as sensory and visual
tracking abnormalities. At 4 years, he was nonambulatory, but
at 5 years, he started crawling, and at 7 years, he was able to use
a stander. Currently, he is able to crawl, sit independently, and
pull-to-stand. He uses a wheelchair, walker, gait trainer, and
bilateral ankle–foot orthoses.
The patient did not speak his first word until 2 years. At
present, he is still essentially nonverbal but has slightly more
advanced receptive abilities, including communication by pic-
ture board and understanding of simple learning games.
Although he has a limited appreciation of paralinguistic fea-
tures (eg, eye contact, intonation, gesture, facial expression), he
enjoys being with people and smiles appropriately. The patient
is currently enrolled in third grade and receives physical and
occupational and swimming therapy.
The patient had corrective surgery for strabismus at 2 years.
A swallow study showed dysphagia and aspiration of thin
liquids; therefore, he was fed only thickened liquids until
7 years. At approximately 8 years, the patient was diagnosed
with kyphoscoliosis and coxa valga. Between the ages of
5 and 9 years, he had recurrent episodes of epistaxis.
His most recent examination at 10 years was notable for
some dysmorphic facial features, including synophrys, hirsut-
ism, low frontal hairline, bushy eyebrows, long eyelashes,
deep-set eyes, large ears, and a bifid uvula (Figure 1B). His
occipital frontal circumference was 52 cm (15th percentile),
weight was 35.4 kg (56th percentile), height was 130 cm (7th
percentile), and body mass index was 20.1 (88th percentile).
Dermatologic examination showed palmoplantar keratoderma
(Figure 1C and D) with focal areas of hyperkeratosis, eczema-
tous dermatitis on the upper arms, and xerosis of the upper and
lower extremities. Genitourinary examination demonstrated a
Tanner III male with adherent prepuce and chordee. Neurolo-
gic examination revealed increased muscle tone in his lower
extremities with significant spasticity in his hamstrings and
adductors, decreased muscle tone in his right upper extremity,
and truncal hypotonia. Deep tendon reflexes were 2/4 in upper
extremities and 3/4 in lower limbs with no clonus. His muscle
bulk and sensation were preserved. Musculoskeletal examina-
tion showed bilateral mild fifth finger and second and fourth
toe clinodactyly. Ophthalmological assessment revealed high
bilateral astigmatism and optic nerve dysplasia with reduced
optic disc diameter.
Brain MRI at 3 years of age showed dysgenesis of the cor-
pus callosum, bilateral frontoparietal polymicrogyria with
abnormal cortical folding, diffuse white matter T2 hyperinten-
sity predominately in the centrum semi ovale (Figure 2A-C),
and hypoplastic intraconal optic nerves (Figure 2D and E).
Materials and Methods
The institutional review board of Washington University School of
Medicine approved our genetic testing protocol. After informed
Figure 2. Brain magnetic resonance imaging (MRI) findings in the proband. A, Sagittal T1-weighted magnetic resonance (MR) sequence
demonstrates dysgenesis of the corpus callosum. Specifically, the splenium of the corpus callosum is hypoplastic (hollow arrow). B, Axial T2-
weighted fluid-attenuated inversion recovery (FLAIR) MR sequence reveals marked hyperintensity in the white matter of the centrum semi ovale
(yellow arrows). C, Axial T2-weighted turbo spin echo (TSE) MR sequence is notable for bilateral frontoparietal polymicrogyria and abnormal
cortical folding (white arrows). D, The intraconal optic nerves are hypoplastic (black circles). E, The optic chiasm (down arrow), the intracranial
optic nerves, and optic tracts are normal.
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consent was obtained from the patient’s parents, DNA was isolated
from the proband’s and his parents’ blood samples using standard
methods. Exome sequencing was performed using a trio design. Exon
targets were isolated by capture using the Agilent Clinical Research
Exome kit (Agilent Technologies, Santa Clara, California) and
sequenced on the Illumina HiSeq 2000 system with 100 base pair
paired-end reads. Sequence data were assembled using human genome
build GRCh37/UCSC hg19. The mean depth of coverage was 139x,
with 10x coverage across 97.2% of the exome. Variants were eval-
uated using Xome Analyzer software (GeneDx, Gaithersburg, Mary-
land). Kinship coefficients from exome sequencing data were
calculated using kinship-based inference to control for misspecified
relationships and reported consanguinity for relations as distant as
second cousins. Capillary sequencing confirmed SNAP29 variant
c.85C>T (p.Arg29X).
Molecular Characterization
Chromosomal microarray analysis showed multiple regions of homo-
zygosity/segmental uniparental disomy identified on chromosomes 1,
4, 19, 21, and 22. Exome sequencing identified a homozygous patho-
genic change designated as c.85C>T (p.Arg29X) in the SNAP29 gene.
This variant has not been observed in approximately 6500 individuals
who were sequenced as part of the National Heart, Lung, and Blood
Institute exome sequence project or in ExAc database (http://
exac.broadinstitute.org/).11,12 Both parents are heterozygous for this
mutation.
Discussion
The authors describe a patient with a homozygous nonsense
mutation in SNAP29 associated with cerebral dysgenesis,
neuropathy, ichthyosis, and keratoderma syndrome. This
variant is predicted to cause loss of normal protein function
either through protein truncation or nonsense-mediated
messenger RNA decay. In our proband, the mutation in the
SNAP29 gene is associated with global developmental delay,
polymicrogyria, optic nerve dysplasia, gaze apraxia, and
scoliosis. Physical abnormalities also include dysmorphic
features such as synophrys, bushy eyebrows, long eyelashes,
deep-set eyes, large ears, fifth finger clinodactyly bilaterally,
and broad first toes bilaterally. Our patient shares many
features with the patients previously reported with SNAP29
mutations (Table 1).5-7 The neurocutaneous symptoms in
cerebral dysgenesis, neuropathy, ichthyosis, and keratoderma
syndrome reflect the common embryonic origin of the
epidermis and neural tissues.
All previously reported patients with cerebral dysgenesis,
neuropathy, ichthyosis, and keratoderma syndrome, including
the patient in this report, presented with severe global devel-
opmental delay and intellectual disability, which are probably
related to SNAP29’s function as a negative modulator of
neurotransmitter release.13 Specifically, SNAP29 has been
shown to play an important role in the recycling of clathrin-
dependent and clathrin-independent ligands in fibroblasts.
Fibroblasts of human patients with cerebral dysgenesis,
neuropathy, ichthyosis, and keratoderma syndrome show
impaired endocytic recycling due to reduced expression of
transferrin and B1-integrin and altered destruction of focal
adhesion complexes.9 A decreased amount of SNAP29 may
slow the recycling of vesicle fusion proteins, leading to
increased neurotransmitter release and eventually the
neurological symptoms seen in patients with cerebral
dysgenesis, neuropathy, ichthyosis, and keratoderma
syndrome.
Furthermore, all patients with cerebral dysgenesis, neuropa-
thy, ichthyosis, and keratoderma syndrome have developed
palmoplantar keratoderma and generalized ichthyosis. These
dermatological manifestations demonstrate SNAP29’s
integral role in proper cell motility and migration, as well as
cell spreading and wound healing.9 During normal
development, the epidermis is formed when keratinocytes
migrate upward from the basal cell layer and transform into
spinous, granular, and cornified cells.5 The epidermal barrier of
the skin is made of a cornified cell envelope, extracellular lipid
layers, and keratin filaments. Lamellar bodies, which are
secretory organelles found in the Golgi complex of
keratinocytes, are found in granular cells and typically
release glucosylceramides, kallikrein-5, and kallikrein-7 into
the extracellular space beneath the stratum corneum to aid
the cells in desquamation and reinforce the epidermal barrier
by forming an lipid membrane impermeable to water. SNAP29
is necessary for epidermal differentiation and barrier formation
because it allows lamellar bodies to secrete their contents into
the extracellular space. In cerebral dysgenesis, neuropathy,
ichthyosis, and keratoderma syndrome, lamellar granules are
abnormally retained in the cornified layer, making them unable
to secrete their contents into the extracellular space.5 This
prevents the cells separating from each other and the
epidermal layer thickens considerably as a response to this
impaired barrier formation process.
Several lines of evidence support the pathogenicity of the
SNAP29 mutations and their association with the previously
mentioned phenotypes. A previous report documented the
220delG SNAP29 mutation in 2 unrelated, consanguineous
Arab families with cerebral dysgenesis, neuropathy,
ichthyosis, and keratoderma syndrome features. This
mutation in SNAP29 was expected to cause loss of the
protein function.5 All 7 affected children from these 2
families had failure to thrive, roving eye movements, and
poor head and trunk control in the first 4 months of life,
similar to our patient. They also had progressive
microcephaly, facial dysmorphisms including elongated
faces, antimongoloid eye slant, slight hypertelorism, and a
flat broad nasal root, as well as palmoplantar keratoderma
and ichthyosis. By 15 months of age, all patients
demonstrated severe intellectual disability and were unable to
sit or walk without assistance. Brain MRIs in 4 patients showed
corpus callosum abnormalities, as well as cortical dysplasia
with pachygyria and polymicrogyria, as seen in our patient as
well. Three of the patients died of aspiration pneumonia
between 5 and 12 years of age. A subsequent study further
elucidated the pathogenesis of cerebral dysgenesis,
neuropathy, ichthyosis, and keratoderma syndrome by
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identifying a novel homozygous insertion in SNAP29 at
complementary DNA position 486, which caused a
frameshift mutation and a truncated protein due to premature
termination of translation 5 amino acids downstream to the
mutation.6 Transfection of wild-type and complementary
DNA constructs with the same insertion in SNAP29 seen in
these patients resulted in the production of truncated and
mislocated protein. An additional report described 2 female
Table 1. Clinical and Molecular Characteristics of Patients With Cerebral Dysgenesis, Neuropathy, Ichthyosis, and Keratoderma Syndrome.
Characteristic Patient 1 (This Report) Sprecher et al5,a Fuchs-Telem et al6,a
Ben-Salem
et al7,a Total (12 Patients)a
Mutation c.85C>T (p.Arg29X) c.220delG (7/7) c.486insA (2/2) c.220delG (2/2)
Sex Male Male (4/7), female
(3/7)
Male (1/2), female (1/2) Female (2/2) Male (6/12), female
(6/12)
Ethnicity Jordanian Arab Israeli Arab (7/7) Pakistani (2/2) Jordanian Arab
(2/2)
Consanguinity Yes Yes Yes Yes 12/12
Hearing Normal Mild loss (3/3) Moderate (1/2), profound
(1/2) loss
Normal Hearing loss (5/5)









Brain MRI Abnormal corpus callosum,
frontoparietal polymicrogyria,
abnormal cortical folding,









































Skeletal Coxa valga, bilateral broad first
toes, digit clinodactyly,
neuromuscular scoliosis



















































Miscellaneous Hirsutism, frequent epistaxis,















Abbreviations: DTRs, deep tendon reflexes; GDD, global developmental delay; NA, not available; OFC, occipitofrontal circumference.
aDenominator can be different from total if not all patients were assessed for a specific item.
bThe facial features were not recurrent or recognizable.
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siblings with the 220delG mutation causing cerebral
dysgenesis, neuropathy, ichthyosis, and keratoderma without
polymicrogyria.7 Finally, mutations in SNAP29 have been
shown to unmask an autosomal recessive condition in
patients with 22q11.2 deletion syndromes similar to cerebral
dysgenesis, neuropathy, ichthyosis, and keratoderma.8 Patients
who have both hemizygous deletions of 22q11.2 and mutations
in SNAP29 exhibit neurological and cutaneous features of
cerebral dysgenesis, neuropathy, ichthyosis, and keratoderma
syndrome. The neurological phenotypes and neuroradiological
findings are more severe than in patients with the deletion only.
In summary, the authors report a fourth family with cere-
bral dysgenesis, neuropathy, ichthyosis, and keratoderma syn-
drome caused by a novel homozygous nonsense SNAP29
mutation. SNAP29 haploinsufficiency causes a unique
neurodevelopmental phenotype encompassing global
developmental delay, polymicrogyria, cerebral dysgenesis,
optic nerve dysplasia/hypoplasia, some dysmorphic features,
ichthyosis, and keratoderma. Additional reports are needed to
better define the molecular and phenotypic spectrum associated
with abnormal intracellular transport processes.
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